TORONTO, June 19, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company"), Canada's largest and fastest growing network of independent pharmacies, is pleased to announce the acquisition of 6 additional pharmacies across Canada.
Neighbourly recently acquired 5 locations in Saskatchewan, Nova Scotia and British Columbia in separate transactions, with an additional acquisition of a location in British Columbia scheduled to close in late June, pending customary regulatory approvals and the satisfaction of customary closing conditions.
"These acquisitions reflect the ongoing execution of our proven acquisition strategy. We remain focused on continuing to grow our network of pharmacies and serving more communities across Canada," said Skip Bourdo, Chief Executive Officer of Neighbourly. "These locations are important healthcare providers within their respective communities, and we are delighted to welcome them to the Neighbourly family."
About Neighbourly Pharmacy Inc.
Neighbourly is Canada's largest and fastest growing network of community pharmacies. United by their patient first focus and their role as essential and trusted healthcare hubs within their communities, Neighbourly's pharmacies strive to provide accessible healthcare with a personal touch. Since 2015, Neighbourly has expanded its diversified national footprint across 7 provinces, reinforcing the Company's reputation as the industry's acquirer of choice.
For more information, please visit www.neighbourlypharmacy.ca. For pharmacy owners considering the sale of their pharmacy, please visit www.neighbourlypharmacy.ca/selling-your-pharmacy.
February 13, 2024 January 23, 2024 January 15, 2024 November 13, 2023 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load